US OptionsDetailed Quotes

MMS250117P125000

Watchlist

0.00
0.000.00%

15min DelayClose Jan 22 09:30 ET

0.00High0.00Low

Maximus Stock Discussion

Moomoo AI

Feb 9, 2024 04:58

Despite flat earnings, Maximus's dividend is seen as sustainable due to profit and cash flow coverage, and a low payout ratio. However, the lack of earnings growth raises concerns, and the dividend may face cuts. The company isn't an immediate buy for its dividend.

Maximus, Inc. (NYSE:MMS) Goes Ex-Dividend Soon

Moomoo AI

Jan 2, 2024 07:31

Insider selling at Maximus, especially at lower prices, may indicate that the insiders think the shares are at peak value or the company's future is not promising. Despite high insider ownership, recent sale activities may warrant caution.

Insiders At Maximus Sold US$5.1m In Stock, Alluding To Potential Weakness

Moomoo AI

Dec 15, 2023 05:32

Maximus' declining ROCE trend and the absence of sales growth despite increased capital investments imply potentially unfavorable prospects for large-scale growth. This may dissuade multi-bagger seeking investors.

Returns On Capital At Maximus (NYSE:MMS) Paint A Concerning Picture

Moomoo Breakfast US

Sep 2, 2022 08:01

Columns Today's Pre-Market Stock Movers: AVGO, RKLB, LULU, XOM and More

Gapping up
In reaction to earnings/guidance:
• $HashiCorp (HCP.US)$ +16.8%, $Lululemon Athletica (LULU.US)$ +9.7%, $PagerDuty (PD.US)$ +5%, $nCino (NCNO.US)$ +3.8% (also Bank Operating System selected by Rabobank Australia and New Zealand), $Broadcom (AVGO.US)$ +2.1%
Other news:
• $Ooma (OOMA.US)$ +3.5% (acquires Junction Networks also reports earnings)
• $Momentus (MNTS.US)$ +3.5% (files for $200 mln mixed securities shelf offering)
• $Humacyte (HUMA.US)$ +2.9% (fi...

No comment yet